Skip to main navigation Skip to search Skip to main content

A randomised, double-blind, dose-finding, phase II multicentre study of ODX in the treatment of patients with castration-resistant prostate cancer and skeletal metastases

  • Camilla Thellenberg-Karlsson
  • , Egils Vjaters
  • , Marju Kase
  • , Teuvo Tammela
  • , Kristiina Ojamaa
  • , Ulf Norming
  • , Claes Nyman
  • , Sven-Olof Andersson
  • , Oleg Hublarovs
  • , Marcela Marquez-Holmberg
  • , Enrique Castellanos
  • , Anders Ullen
  • , Anders Holmberg
  • , Sten Nilsson

    Research output: Contribution to journalArticleScientificpeer-review

    6 Citations (Scopus)
    11 Downloads (Pure)

    Abstract


    Original languageEnglish
    Pages (from-to)198-207
    Number of pages10
    JournalEuropean Journal of Cancer
    Volume181
    Early online date20 Dec 2022
    DOIs
    Publication statusPublished - 20 Jan 2023
    Publication typeA1 Journal article-refereed

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Publication forum classification

    • Publication forum level 2

    Cite this